Rapid methods of detecting the target molecule in immunohistology using a bioluminescence probe

被引:12
作者
Wu, Chun [1 ]
Wang, Ke-Yong [2 ]
Guo, Xin [2 ]
Sato, Masanori [3 ]
Ozaki, Michitaka [3 ]
Shimajiri, Shyohei [2 ]
Ohmiya, Yoshihiro [3 ,4 ]
Sasaguri, Yasuyuki [2 ]
机构
[1] AIST, Hlth Res Inst, Osaka, Japan
[2] Univ Occupat & Environm Hlth, Dept Pathol & Cell Biol, Sch Med, Kita Kyusyu, Japan
[3] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan
[4] AIST, Bioprod Res Inst, Ibaraki, Japan
关键词
bioluminescent probe; immunohistochemistry; luciferase; luciferin; disease-specific antigens; CARCINOEMBRYONIC ANTIGEN CEA; ENZYME-IMMUNOASSAY; TUMOR-MARKER; CHEMILUMINESCENCE; LUCIFERASE;
D O I
10.1002/bio.2333
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
We demonstrate a novel rapid direct detection method for immunohistochemistry, using a bioluminescent probe. An anti-CEA antibody-fused far-red bioluminescent protein can monitor the accumulation of this type of probe in tumour tissues. The bimodal spectrum (max=460 and 675nm) of this bioluminescent probe is extremely stable under different conditions of pH and ion concentration. The sensitivity of our bioluminescent labelling was at the same level of enzymatic labelling, e.g. peroxidase, as an indirect system. Our novel technique is simple and can shorten the pretreatment time of paraffin sections to around 30min. The utility of our bioluminescent labelling covers all imaging in vitro, in vivo and ex vivo, suggesting that our antibody-fused bioluminescent probe has the potential to detect tumour antigens with a high sensitivity in routine immune histological examinations. Copyright (c) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 18 条
  • [1] ENZYME MARKERS - THEIR LINKAGE WITH PROTEINS AND USE IN IMMUNO-HISTOCHEMISTRY
    AVRAMEAS, S
    [J]. HISTOCHEMICAL JOURNAL, 1972, 4 (04): : 321 - &
  • [2] Coons AH, 1941, P SOC EXP BIOL MED, V47, P200, DOI 10.3181/00379727-47-13084P
  • [3] DOYLE PJ, 1981, CLIN ONCOL, V7, P53
  • [4] CEA (CARCINOEMBRYONIC-ANTIGEN) - ITS ROLE AS A MARKER IN THE MANAGEMENT OF CANCER
    GOLDENBERG, DM
    NEVILLE, AM
    CARTER, AC
    GO, VLW
    HOLYOKE, ED
    ISSELBACHER, KJ
    SCHEIN, PS
    SCHWARTZ, M
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1981, 101 (03) : 239 - 242
  • [5] Kricka LJ, 2000, METHOD ENZYMOL, V305, P333
  • [6] Newer developments in immunohistology
    Leong, A. S-Y
    Leong, T. Y-M
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (11) : 1117 - 1126
  • [7] New label enzymes for bioluminescent enzyme immunoassay
    Maeda, M
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 30 (06) : 1725 - 1734
  • [8] Development of ultra-high sensitivity bioluminescent enzyme immunoassay for hepatitis B virus surface antigen using firefly luciferase
    Minekawa, Takayuki
    Ohkuma, Hiroshi
    Abe, Katsushi
    Maekawa, Hiroaki
    Arakawa, Hidetoshi
    [J]. LUMINESCENCE, 2009, 24 (06) : 394 - 399
  • [9] Musiani M, 1998, HISTOL HISTOPATHOL, V13, P243, DOI 10.14670/HH-13.243
  • [10] CDNA cloning and characterization of a secreted luciferase from the luminous Japanese ostracod, Cypridina noctiluca
    Nakajima, Y
    Kobayashi, K
    Yamagishi, K
    Enomoto, T
    Ohmiya, Y
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2004, 68 (03) : 565 - 570